Hillsdale Investment Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-400
Closed -$7.4K 623
2025
Q1
$7.4K Sell
400
-100
-20% -$1.8K ﹤0.01% 505
2024
Q4
$8.24K Buy
+500
New +$7.08K ﹤0.01% 498
2023
Q3
Sell
-270
Closed -$2.46K 569
2023
Q2
$2.46K Sell
270
-61,130
-100% -$570K ﹤0.01% 543
2023
Q1
$580K Sell
61,400
-3,000
-5% -$27.4K 0.05% 283
2022
Q4
$643K Buy
+64,400
New +$715K 0.05% 269

Other funds holding AXGN

Hillsdale Investment Management's AXGN Position: Q2 2025 in Review

Hillsdale Investment Management sold out of Axogen (AXGN) in Q2 2025, closing a stake of 400 shares — an estimated $7.4K sold.

Hillsdale Investment Management first reported a position in AXGN in Q4 2022 and held it in 5 quarters. The position peaked at $643K in Q4 2022. 155 funds tracked by Wall St. Rank hold AXGN as of Q2 2025.

  • Hillsdale Investment Management reported no remaining Axogen position as of Q2 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 400 Axogen shares in Q2 2025, an estimated $7.4K.
  • Hillsdale Investment Management first reported a position in Axogen in Q4 2022 and held it in 5 quarters.
  • Hillsdale Investment Management's Axogen position peaked at $643K in Q4 2022.
  • 155 funds tracked by Wall St. Rank held Axogen as of Q2 2025.

Based on Hillsdale Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.